The Synthesis of Mycobactin Analogs and Heterocyclic Scaffolds From Acylnitroso Hetero-Diels-Alder Cycloadducts
In chapter 2, the rationale behind the synthesis of mycobactin analogs was described. In chapter 3, the synthesis of mycobactin analog fragments is described from amino acids and acylnitroso HDA cycloadducts. Chapter 4 described the assembly of mycobactin analog fragments into fully elaborated and deprotected 1,2-diol-containing mycobactin analogs. General strategies toward the synthesis of α-hydroxy carboxylate-containing mycobactin analogs were also presented as well as interesting results from biological assays on final molecules and intermediates.
In chapter 5, the discovery of a new method for synthesizing imidazole analogs of mycobactin fragments from azides and 2-amidoacrylates was described. The initial reaction, optimization of reaction conditions, and a limited study of reaction scope was presented as well as the results of biological assays performed on selected intermediates. This discovery provided a new method for synthesizing imidazole-containing mycobactin analogs as well as a general method for preparing 1-substituted- and 1,2-disubstituted-imidazole-4-carboxylates in three steps from serine, carboxylic acids, and azides.
Chapter 6 described the development of the addition of azides to acylnitroso HDA cycloadducts and the effect of alkene strain on reactivity. The scope of the reaction was investigated as well as conversion of the triazoline products to aziridines. The significance of this research as it related to the synthesis of aziridine- and triazoline-containing 5'-norcarbocyclic nucleosides and bioconjugation chemistry was also described.
In chapter 7, other ways of utilizing the acylnitroso HDA reaction were investigated. Preliminary results on addition of diazoalkanes to cycloadducts, Brønsted acid-catalyzed opening of cycloadducts, acylnitroso [2+2+2] homo-Diels-Alder reactions, and acylnitroso cycloadditions to indole ortho-quinodimethanes were presented. A discussion of their significance toward the synthesis of biologically useful molecules was also included.
History
Date Modified
2017-06-05Defense Date
2008-05-29Research Director(s)
Robert A. SchulzCommittee Members
Marvin J. Miller Richard E. Taylor Olaf Wiest Xavier CrearyDegree
- Doctor of Philosophy
Degree Level
- Doctoral Dissertation
Language
- English
Alternate Identifier
etd-07152008-095421Publisher
University of Notre DameProgram Name
- Chemistry and Biochemistry